Zosuquidar Trihydrochloride

N/A

Report date: 2026/04/24 20:01:59
NME

Base Information

Drug NameZosuquidar Trihydrochloride
Drug Alias NameZozuquidar TrihydrochloridezosuquidarLY-335979RS-33295-198RS 33295
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP-glycoprotein 1 inhibitors
TargetsP-glycoprotein 1
Therapy Area/IndicationsAnemia, RefractoryLeukemia, Myeloid, AcuteLeukemia, Myeloid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKanisa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKanisa Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAnemia, RefractoryLeukemia, Myeloid, AcuteLeukemia, Myeloid

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG